DMSO-PDT of BCC - A 6 Year Follow up

Norwegian University of Science and Technology44 enrolled

Overview

The purpose of this study is to registrate long time clinical and histological treatment response of basal cell carcinoma (BCC) lesions treated with one or two procedures of dimethylsulfoxide supported 5-aminolaevulinic acid photodynamic therapy (DMSO-PDT).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Carcinoma, Basal Cell

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * histological verified bcc. * one or two PDT treatments with treatment interval no longer than two weeks. * lesion complete response three months after therapy. Exclusion Criteria: * pregnant. * Gorlin's syndrome. * morpheaform or pigmented bcc. * histology older than one year. * tumour infiltration more than four mm. * previous PDT treated lesions.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.